Yujin Jiang

Yujin Jiang

Auto-generated profile, based on publicly available information

Yujin Jiang

Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2025 in Experimental Eye Research
Verified
Journal Article
Closed access
BLBo Li
Bo Li
YJYujin Jiang
Yujin Jiang
YHYikeng Huang
Yikeng Huang
XZXinyu Zhang
Xinyu Zhang
ZZZhi Zheng
Zhi Zheng
SZShuzhi Zhao
Shuzhi Zhao

31 January 2025 in Journal of Global Health
Verified
Journal Article
Open access
YHYikeng Huang
Yikeng Huang
XZXinyu Zhang
Xinyu Zhang
LLLi Liang
Li Liang
YJYujin Jiang
Yujin Jiang
BLBo Li
Bo Li
SZShuzhi Zhao
Shuzhi Zhao
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in elderly individuals aged >55 years in developed countries [1]. Approximately 196 million individuals, or 8.69% of the global population, are affected by AMD. With the increase in life expectancy and population ageing, this number is expected to rise to 288 million by […]

27 June 2025 in Journal of Global Health
Verified
Journal Article
Open access
XZXinyu Zhang
Xinyu Zhang
YHYikeng Huang
Yikeng Huang
MMMingming Ma
Mingming Ma
CZChuandi Zhou
Chuandi Zhou
YJYujin Jiang
Yujin Jiang
SZShuzhi Zhao
Shuzhi Zhao
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in the population aged over 55 years worldwide, with the number of affected individuals projected to reach 288 million by 2040 [1,2]. The advanced stage of AMD manifests in two forms, including geographic atrophy (dry) and neovascular (wet) AMD. Currently, there is no […]

1 January 2026 in Depression and Anxiety
Verified
Journal Article
Open access
BLBo Li
Bo Li
YJYujin Jiang
Yujin Jiang
CLChenxin Li
Chenxin Li
YHYikeng Huang
Yikeng Huang
SZShuzhi Zhao
Shuzhi Zhao
XZXiaofeng Zhang
Xiaofeng Zhang
Purpose: Vision‐threatening diabetic retinopathy (VTDR) poses significant blindness risks and the study aimed to identify the impact of psychological factors on its ocular outcomes. Methods: This retrospective cohort study enrolled 782 VTDR patients from three ophthalmological centers (2018–2021). DR severity was graded using ETDRS criteria. Primary outcomes included tractional retinal detachment (TRD) involving the fovea, neovascular glaucoma (NVG), final best‐corrected visual acuity (BCVA) <0.3, and recurrent vitreous hemorrhage (VH). Anxiety and depression were assessed via the hospital anxiety and depression scale (HADS). Univariable and multivariable logistic regression evaluated the associations between HADS scores and ocular outcomes. Results: After a median follow‐up of 24.8 months, depressive symptoms (HADS‐D ≥8) were associated with higher rates of BCVA <0.3 (67.8% vs. 57.2%, p = 0.033) and NVG (13.6% vs. 6.9%, p = 0.020). Recurrent VH was more frequent in patients with anxiety (21.0% vs. 10.6%, p = 0.031) or depression (20.3% vs. 10.7%, p = 0.045). Multivariable logistic analysis revealed that each 1‐point increase in HADS‐D score significantly increased adjusted odds of TRD (aOR = 1.06, 95% CI: 1.01−1.11), BCVA <0.3 (aOR = 1.07, 95% CI: 1.02−1.11), recurrent VH (aOR = 1.09, 95% CI: 1.02−1.17), and NVG (aOR = 1.10, 95% CI: 1.03−1.17; all p < 0.05). There was a consistent positive gradient between HADS severity and adverse outcomes. Conclusion: Depressive symptoms are independently associated with worse ocular prognoses in VTDR patients. Systematic psychological screening and intervention is essential to mitigate vision deterioration risk in this population.